A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: Analgesic efficacy and tolerability after gynecologic surgery

Anesthesia and Analgesia

Volumn 88, Issue 3, 1999, Pages 611-616

  Varrassi, Giustino ^a   Marinangeli, Franco ^b   Agrò, Felice ^c   Aloe, Luigi ^d   De Cillis, Pompilio ^e   De Nicola, Aniello ^f   Giunta, Francesco ^g   Ischia, Stefano ^h   Ballabio, Maria ^a   Stefanini, Silvia ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d G RUMMO HOSPITAL   (Italy)

^e Castellammare di Stabia   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h Medical Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC; MORPHINE; PARACETAMOL;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG POTENCY; EPIGASTRIC PAIN; GYNECOLOGIC SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL;

EID: 0032975775     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199903000-00028     Document Type: Article

References (29)

1. Kehlet H, Dahl JB. The value of "multimbdal" or "balanced analgesia" in post-operative pain treatment. Anesth Analg 1993; 77:1048-56.
2. McQuay HJ, Carroll D, Watts PG, et al. Codeine 20 mg increases pain relief from ibuprofen 400 mg after third molar surgery: a repeat-dosing comparison of ibuprofen and ibuprofen-codeine combination. Pain 1989;37:7-13.
3. Moffat AC, Kenny GN, Prentice JW. Postoperative nefopam and diclofenac: evaluation of their morphine-sparing effect after upper abdominal surgery. Anaesthesia 1990;45:302-5.
4. Gillies GW, Kenny GN, Bullingham RE, McArdle CS. The morphine sparing effect of ketorolac tromethamine: a study of a new potential non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987;42:727-31.
5. Cataldo PA, Senagore AJ, Kilbride MJ. Ketorolac and patient controlled analgesia in the treatment of postoperative pain. Surg Gynecol Obstet 1993;176:435-8.
6. Parker RK, Holtmann B, Smith J, White PR Use of ketorolac after lower abdominal surgery: effect on analgesic requirement and surgical outcome. Anesthesiology 1994;80:6-12.
7. Depré M, van Hecken A, Verbesselt R, et al. Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use. Fundam Clin Pharmacol 1992;6:259-62.
8. Bannwarth B, Netter P, Lapicque F, et al. Plasma and cérébrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol 1992;34: 79-81.
9. Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 1991;49: 350-4.
10. Delbos A, Boccard E. The morphine-sparing effect of propacetamol in orthopedic postoperative pain. J Pain Symptom Manage 1995;10:279-86.
11. Peduto VA, Ballabio M, Stefanini S. Efficacy of propacetamol in the treatment of postoperative pain: morphine sparing effect in orthopedic surgery. The Italian Collaborative Group on Propacetamol. Acta Anaesthesiol Scand 1998;42:293-8.
12. Monrigal C, Jacob JP, Granry JC. Comparaison de l'efficacité analgésique de la nalbuphine et de son association au propacetamol en phase postopératoire immédiate de chirurgie gynécoobstétricale. Ann Fr Anesth Reanim 1994;13:153-7.
13. Sevarino FB, Sinatra RS, Paige D, et al. The efficacy of intramuscular ketorolac in combination \vith intravenous PCA morphine for postoperative pain relief. J Clin Anesth 1992;4:285-8.
14. Rogers JE, Fleming BG, Macintosh KC, et al. Effect of timing of ketorolac administration on patient-controlled opioid use. Br J Anaesth 1995;75:15-8.
15. Ready LB, Brown CR, Stahlgren LH, et al. Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain: a double-blind, placebo-controlled multicenter study. Anesthesiology 1994;80:1277-86.
16. Varrassi G, Panella L, Piroli A, et al. The effects of perioperative ketorolac infusion on postoperative pain and endocrinemetabolic response. Anesth Analg 1994;78:514-9.
17. Picard P, Bazin JE, Conio N, et al. Ketorolac potentiates morphine in postoperative patient-controlled analgesia. Pain 1997; 73:401-6.
18. Dahl JB, Kehlet H. Non-steroidal anti-inflammatory drugs: rationale for use in severe post-operative pain. Br J Anaesth 1991; 66:703-12.
19. Ang ET, Goldfarb G, Boccard E. Analgesic efficacy of propacetamol hydrochlorate 2g versus pentazocine 30 mg after orthopedic surgery. Eur J Pain 1990;11:137-42.
20. Farkas JC, Larroutrou P, Morin JP, et al. Analgesic efficacy of injectable acetaminophen vs a dipyrone plus pitofenone plus fenpiverinium association after abdominal aortic repair. Curr Ther Res 1992,1:19-27.
21. Garci'a Rodriguez L, Cattaruzzi C, Tronçon M, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998;158:33-9.
22. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991;! 15:787-96.
23. Hubbell K. Problems and pitfalls in providing acute and shortterm pain relief with non-steroidal anti-inflammatory agents. J La State Med Soc 1996;148:13-8.
24. Conrad KA, Fagan TC, Mackie MJ, Mayshar PV. Effects of ketorolac tromethamine on hemostasis in volunteers. Clin Pharmacol Ther 1988;43:542-6.
25. Bean-Lijewsk JD, Hunt RD. Effect of ketorolac on bleeding time and postoperative pain in children: a double-blind, placebocontrolled comparison with meperidine. J Clin Anesth 1996;8: 25-30.
26. Fleming BM, Coombs DW. Bleeding diathesis after perioperative ketorolac [letter]. Anesth Analg 1991;73:235.
27. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
28. Distel M, Mueller C, Bluhmki E, Fries J. Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol 1996;35(Suppl): 68-77.
29. Simon LS, Lanza FL, Lipsky PE, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998;41:1591-602.